Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Optical Coherence Tomography Guided Reperfusion Strategy in Patients With STEMI (EROSION II)

NCT03062826 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT03062826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Optical Coherence Tomography Guided Reperfusion Strategy in Patients With STEMI (EROSION II)
Lead sponsor
Harbin Medical University
Phase
Observational
Overall status
Unknown status
Start date
January 11, 2017
Completion date
March 1, 2023
Enrollment
347 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

st-segment elevation myocardial infarction